TABLE 2.
Five-Year Relative Survival of Individuals Younger Than 20 Years Diagnosed With Malignant Cancer in the United States, 2001–2015
| 2001–2015 |
2001–2007 |
2008–2015 |
||||
|---|---|---|---|---|---|---|
| Characteristic | Count | Relative Survival, % (95% CI) | Count | Relative Survival, % (95% CI) | Count | Relative Survival, % (95% CI) |
|
| ||||||
| Overall | 185,312 | 83.5 (83.3–83.7) | 89,275 | 82.0 (81.8–82.3) | 96,037 | 85.1 (84.9–85.4) |
| Sex | ||||||
| Male | 99,191 | 82.6 (82.4–82.9) | 47,970 | 81.1 (80.7–81.4) | 51,221 | 84.3 (83.9–84.6) |
| Female | 86,121 | 84.6 (84.3–84.8) | 41,305 | 83.2 (82.8–83.5) | 44,816 | 86.1 (85.7–86.4) |
| Age, y | ||||||
| 0–14 | 126,243 | 83.1 (82.9–83.4) | 60,547 | 81.6 (81.3–81.9) | 65,696 | 84.8 (84.5–85.1) |
| 0–4 | 58,728 | 83.8 (83.5–84.1) | 28,243 | 82.3 (81.9–82.8) | 30,485 | 85.3 (84.9–85.8) |
| 5–9 | 31,612 | 83.0 (82.5–83.4) | 14,820 | 81.4 (80.7–82.0) | 16,792 | 84.6 (84.0–85.2) |
| 10–14 | 35,903 | 82.2 (81.8–82.7) | 17,484 | 80.7 (80.1–81.2) | 18,419 | 84.1 (83.5–84.6) |
| 15–19 | 59,069 | 84.3 (84.0–84.6) | 28,728 | 83.0 (82.5–83.4) | 30,341 | 85.8 (85.3–86.2) |
| Racial/ethnic groupa | ||||||
| White, non–Hispanic | 112,198 | 85.2 (85.0–85.4) | 56,239 | 83.9 (83.6–84.2) | 55,959 | 86.7 (86.4–87.0) |
| Black, non–Hispanic | 22,228 | 77.8 (77.2–78.3) | 10,587 | 75.8 (74.9–76.6) | 11,641 | 79.9 (79.0–80.6) |
| Hispanic | 39,320 | 81.8 (81.3–82.2) | 17,392 | 79.5 (78.9–80.1) | 21,928 | 83.8 (83.2–84.3) |
| AI/AN, non–Hispanic | 1553 | 80.9 (78.7–82.9) | 723 | 79.8 (76.7–82.6) | 830 | 81.6 (78.4–84.4) |
| API, non–Hispanic | 7418 | 82.6 (81.7–83.5) | 3200 | 80.6 (79.2–81.9) | 4218 | 84.3 (83.1–85.5) |
| County–level economic statusb | ||||||
| Top 25% | 49,317 | 85.1 (84.8–85.4) | 23,495 | 83.6 (83.2–84.1) | 25,822 | 86.6 (86.2–87.1) |
| Middle 25%–75% | 108,946 | 83.1 (82.9–83.4) | 52,835 | 81.7 (81.3–82.0) | 56,111 | 84.7 (84.4–85.1) |
| Lower 25% | 23,050 | 81.5 (81.0–82.0) | 11,001 | 79.9 (79.1–80.6) | 12,049 | 83.2 (82.4–83.9) |
| US Census region | ||||||
| Northeast | 34,754 | 85.3 (84.9–85.7) | 17,157 | 83.9 (83.4–84.5) | 17,597 | 86.8 (86.3–87.4) |
| Midwest | 35,050 | 84.2 (83.7–84.6) | 17,344 | 83.1 (82.6–83.7) | 17,706 | 85.3 (84.8–85.9) |
| West | 44,128 | 82.8 (82.5–83.2) | 21,257 | 80.9 (80.4–81.4) | 22,871 | 84.8 (84.3–85.3) |
| South | 71,380 | 82.8 (82.5–83.1) | 33,517 | 81.2 (80.8–81.6) | 37,863 | 84.4 (84.0–84.8) |
| Cause of death | ||||||
| Liver | 2678 | 68.4 (66.6–70.2) | 1239 | 64.3 (61.5–66.9) | 1439 | 72.5 (69.9–74.9) |
| Bones and joints | 9423 | 70.7 (69.7–71.6) | 4739 | 70.1 (68.8–71.4) | 4684 | 71.3 (69.7–72.8) |
| Soft tissue, including heart | 10,829 | 75.9 (75.1–76.8) | 5298 | 75.4 (74.3–76.6) | 5531 | 76.3 (75.0–77.5) |
| Melanoma of skin | 5192 | 96.1 (95.5–96.6) | 3021 | 96.5 (95.7–97.1) | 2171 | 95.5 (94.3–96.4) |
| Female genital system | 3878 | 91.0 (90.1–91.9) | 1932 | 90.6 (89.2–91.9) | 1946 | 91.5 (90.0–92.7) |
| Male genital system | 6145 | 94.6 (93.9–95.2) | 2971 | 94.2 (93.3–95.0) | 3174 | 94.9 (94.0–95.7) |
| Brain and other nervous system | 33,631 | 75.3 (74.8–75.8) | 16,272 | 74.1 (73.4–74.7) | 17,359 | 76.7 (76.0–77.4) |
| Endocrine system | 14,385 | 87.9 (87.4–88.5) | 6362 | 86.0 (85.1–86.8) | 8023 | 89.9 (89.1–90.6) |
| Kidney and renal pelvis | 7506 | 89.3 (88.6–90.0) | 3603 | 87.4 (86.3–88.4) | 3903 | 91.3 (90.3–92.3) |
| Lymphoma | 25,365 | 91.6 (91.2–91.9) | 12,484 | 90.0 (89.5–90.6) | 12,881 | 93.2 (92.7–93.7) |
| Hodgkin lymphoma | 13,242 | 96.0 (95.6–96.3) | 6603 | 95.3 (94.8–95.8) | 6639 | 96.7 (96.2–97.2) |
| Non–Hodgkin lymphoma | 12,123 | 86.7 (86.1–87.4) | 5881 | 84.1 (83.2–85.1) | 6242 | 89.4 (88.5–90.2) |
| Leukemia | 46,102 | 83.3 (82.9–83.6) | 22,424 | 81.1 (80.6–81.6) | 23,678 | 85.7 (85.2–86.2) |
| Acute lymphocytic leukemia | 34,784 | 88.2 (87.9–88.6) | 16,782 | 86.8 (86.2–87.3) | 18,002 | 89.9 (89.3–90.3) |
| Acute myeloid leukemia | 7252 | 64.7 (63.6–65.9) | 3570 | 60.9 (59.3–62.5) | 3682 | 69.0 (67.3–70.6) |
Abbreviations: AI/AN, American Indian/Alaska Native; API, Asian/Pacific Islander; CI, confidence interval.
The source for the data is the National Program of Cancer Registries (Centers for Disease Control and Prevention). Bolding indicates nonoverlapping 95% CIs when 2001–2007 and 2008–2015 are compared.
a
Hispanic persons might be of any race; 2595 cases of unknown race during 2001–2015 were excluded.
b
Excluded 3999 cases with missing economic status.